Post–Covid-19 Cholangiopathy—A New Indication for Liver Transplantation: A Case Report
| Autor: | Joohyun Kim, Juan Pablo Trivella, Johnny C. Hong, John J. Evans, Allyssa A. Nicholas, Veronica Loy, Jennifer J. Mahaffey, Michael A. Zimmerman, Francisco Durazo, Shannon Sova |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Orthotopic liver transplantation Coronavirus disease 2019 (COVID-19) medicine.medical_treatment Population Secondary sclerosing cholangitis in critically ill patients (SSC-CIP) 030230 surgery Liver transplantation Liver tests Gastroenterology Article End Stage Liver Disease 03 medical and health sciences Liver disease Post-Acute COVID-19 Syndrome 0302 clinical medicine Internal medicine medicine Humans education Liver injury Transplantation education.field_of_study SARS-CoV-2 business.industry COVID-19 Middle Aged medicine.disease Liver Transplantation surgical procedures operative Post-COVID-19 cholangiopathy Liver Secondary sclerosing cholangitis 030211 gastroenterology & hepatology Surgery business |
| Zdroj: | Transplantation Proceedings |
| ISSN: | 0041-1345 |
| DOI: | 10.1016/j.transproceed.2021.03.007 |
| Popis: | Liver injury is one of the nonpulmonary manifestations described in coronavirus disease 2019 (COVID-19). Post-COVID-19 cholangiopathy is a special entity of liver injury that has been suggested as a variant of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). In the general population, the outcome of SSC-CIP has been reported to be poor without orthotopic liver transplantation (OLT). However, the role of OLT for post-COVID-19 cholangiopathy is unknown. We present a case report of a 47-year-old man who recovered from acute respiratory distress syndrome from COVID-19 and subsequently developed end-stage liver disease from post-COVID-19 cholangiopathy. The patient underwent OLT and is doing well with normal liver tests for 7 months. To our knowledge, this is the first case report of a patient who underwent successful liver transplantation for post-COVID-19 cholangiopathy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect